1,4-bis(2-(3,5-dichloropyridyloxy))benzene has been researched along with Non-alcoholic Fatty Liver Disease in 1 studies
1,4-bis(2-(3,5-dichloropyridyloxy))benzene: potent phenobarbital-like inducer of microsomal monooxygenase activity; structure given in first source
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takizawa, D | 1 |
| Kakizaki, S | 1 |
| Horiguchi, N | 1 |
| Yamazaki, Y | 1 |
| Tojima, H | 1 |
| Mori, M | 1 |
1 other study available for 1,4-bis(2-(3,5-dichloropyridyloxy))benzene and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Constitutive active/androstane receptor promotes hepatocarcinogenesis in a mouse model of non-alcoholic steatohepatitis.
Topics: Animals; Cell Proliferation; Choline Deficiency; Constitutive Androstane Receptor; Disease Models, A | 2011 |